Cloned (Comment) | Organism |
---|---|
expressed in Escherichia coli NADH dehydrogenase knockout strain ANN0222 | Plasmodium falciparum |
expression in Escherichia coli | Plasmodium falciparum |
General Stability | Organism |
---|---|
not stable to repeated freeze-thaw cycles | Plasmodium falciparum |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-hydroxy-2-dodecyl-4(1H)-quinolone | - |
Plasmodium falciparum | |
1-hydroxy-2-dodecyl-4(1H)quinolone | - |
Plasmodium falciparum | |
1-hydroxy-2-octyl-4(1H)quinolone | - |
Plasmodium falciparum | |
diphenylene iodonium chloride | - |
Plasmodium falciparum |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0051 | - |
NADH | cosubstrate: decylubiquinone | Plasmodium falciparum | |
0.0167 | - |
NADH | cosubstrate: ubiquinone-1 | Plasmodium falciparum |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
membrane | the membrane-bound respiratory enzymes differs from the canonical NADH: dehydrogenase (complex I), because it is not involved in the vectorial transfer of protons across membranes. The enzyme possesses an amphipathic alpha-helix, which is likely to anchor the enzyme into the lipid bilayer | Plasmodium falciparum | 16020 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
NADH + H+ + atovaquone | Plasmodium falciparum | atovaquone is 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione | NAD+ + reduced atovaquone | - |
? | |
NADH + H+ + ubiquinone | Plasmodium falciparum | the enzyme plays an essential role in maintaining a reduced ubiquinone-pool during infection (Plasmodium falciparum is the causative agents of malaria). The enzyme is not only essential to parasite survival in vivo but may also contribute to the severity and outcome of disease. Type II NADH:quinone oxidoreductase the membrane-bound respiratory enzyme differs from the canonical NADH:dehydrogenase (complex I), because it is not involved in the vectorial transfer of protons across membranes. In the electron transport chain of Plasmodium, the canonical multimeric complex I (NADH:dehydrogenase) found in mammalian mitochondria is absent, and, instead, the parasite possesses five quinone-dependent oxidoreductases, namely a type II NADH:quinone oxidoreductase (PfNDH2), a malate: quinone oxidoreductase (MQO), a dihydroorotate dehydrogenase (DHOD), a glycerol-3-phosphate dehydrogenase (G3PDH), and a succinate: quinone oxidoreductase (SDH). These enzymes link cytosolic metabolism to mitochondrial metabolism, generating reducing power (ubiquinol) for the bc1 complex and an aa3-type cytochrome oxidase, enabling proton pumping and energy conservation | NAD+ + ubiquinone | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Plasmodium falciparum | - |
- |
- |
Storage Stability | Organism |
---|---|
-80°C, stable for at least 6 months | Plasmodium falciparum |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
NADH + H+ + atovaquone | atovaquone is 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione | Plasmodium falciparum | NAD+ + reduced atovaquone | - |
? | |
NADH + H+ + ubiquinone | the enzyme plays an essential role in maintaining a reduced ubiquinone-pool during infection (Plasmodium falciparum is the causative agents of malaria). The enzyme is not only essential to parasite survival in vivo but may also contribute to the severity and outcome of disease. Type II NADH:quinone oxidoreductase the membrane-bound respiratory enzyme differs from the canonical NADH:dehydrogenase (complex I), because it is not involved in the vectorial transfer of protons across membranes. In the electron transport chain of Plasmodium, the canonical multimeric complex I (NADH:dehydrogenase) found in mammalian mitochondria is absent, and, instead, the parasite possesses five quinone-dependent oxidoreductases, namely a type II NADH:quinone oxidoreductase (PfNDH2), a malate: quinone oxidoreductase (MQO), a dihydroorotate dehydrogenase (DHOD), a glycerol-3-phosphate dehydrogenase (G3PDH), and a succinate: quinone oxidoreductase (SDH). These enzymes link cytosolic metabolism to mitochondrial metabolism, generating reducing power (ubiquinol) for the bc1 complex and an aa3-type cytochrome oxidase, enabling proton pumping and energy conservation | Plasmodium falciparum | NAD+ + ubiquinone | - |
? | |
NADH + H+ + ubiquinone-1 | - |
Plasmodium falciparum | NAD+ + ubiquinol-1 | - |
? | |
NADH + H+ + ubiquinone-10 | - |
Plasmodium falciparum | NAD+ + ubiquinol-10 | - |
? | |
NADPH + H+ + ubiquinone-1 | - |
Plasmodium falciparum | NADP+ + ubiquinol-1 | - |
? | |
NADPH + H+ + ubiquinone-10 | - |
Plasmodium falciparum | NADP+ + ubiquinol-10 | - |
? |
Synonyms | Comment | Organism |
---|---|---|
NDH2 | - |
Plasmodium falciparum |
PfNdh2 | - |
Plasmodium falciparum |
type II NADH: quinone oxidoreductase | - |
Plasmodium falciparum |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.5 | - |
assay at | Plasmodium falciparum |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
FAD | - |
Plasmodium falciparum | |
NADH | PfNDH2 can use both NADH and NADPH as electron donor | Plasmodium falciparum | |
NADH | NDH2 can use both NADH and NADPH as electron donor | Plasmodium falciparum | |
NADPH | PfNDH2 can use both NADH and NADPH as electron donor | Plasmodium falciparum | |
NADPH | NDH2 can use both NADH and NADPH as electron donor | Plasmodium falciparum |